Finance

Lists
ARDX:NASDAQ
Ardelyx Inc
$3.71
-2.37%
(-0.090) 1D
$3.70
-0.15% (-0.0054)
After hours
Closed: Sep 3, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARDX...
Open
$3.80
High
$3.83
Low
$3.68
Mkt. cap
924.49M
Avg. vol.
4.40M
Volume
3.47M
52-wk high
$8.40
52-wk low
$3.68
EPS
-$0.23
Beta
0.70
Shares outstanding
249.19M
No. of employees
489
Open
$3.80
High
$3.83
Low
$3.68
Mkt. cap
924.49M
Avg. vol.
4.40M
Volume
3.47M
52-wk high
$8.40
52-wk low
$3.68
EPS
-$0.23
Beta
0.70
Shares outstanding
249.19M
No. of employees
489
About Ardelyx Inc
CEOMike Raab
Employees489
Founded2007
Headquarters-
SectorBiotechnology
Websiteardelyx.com
Analyst ratings
Based on 8 analysts giving stock ratings to ARDX in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ARDX in the last 3 months.
Highest
Current $3.71
$18.00 (+385.18%)
Average
$13.63 (+267.39%)
Lowest
$9.00 (+142.59%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Buy
Maintained
$9.00
+142.6%
08/18/2026
Laura Chico
Wedbush
Buy
Maintained
-
-
08/17/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$15.00
+304.3%
08/17/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Reiterated
$16.00
+331.3%
08/10/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$11.00
+196.5%
08/10/2026
Christopher Raymond
Raymond James
Buy
Maintained
$15.00
+304.3%
08/07/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$18.00
+385.2%
08/07/2026
Joseph Thome
TD Cowen
Buy
Maintained
$10.00
+169.5%
08/06/2026
Unknown Analyst
Wedbush
Buy
Maintained
$19.00
+412.1%
07/13/2026
Dennis Ding
Jefferies
Buy
Maintained
$15.00
+304.3%
06/26/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
$16.00
+331.3%
06/16/2026
Julian Harrison
BTIG
Buy
Reiterated
$17.00
+358.2%
02/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
110.33M
125.22M
94.47M
120.88M
Cost of goods sold
22.05M
33.70M
25.00M
31.86M
Cost of revenue
22.05M
33.70M
25.00M
31.86M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.61M
86.41M
102.27M
101.44M
Operating expense
83.61M
86.41M
102.27M
101.44M
Total operating expenses
105.66M
120.12M
127.27M
133.30M
Operating income
4.67M
5.10M
-32.79M
-12.42M
Other non operating income
2.45M
2.08M
2.11M
2.04M
EBT including unusual items
-867.00K
-400.00K
-37.60M
-16.61M
EBT excluding unusual items
-867.00K
-400.00K
-37.60M
-16.61M
Income tax expense
102.00K
7.00K
8.00K
110.00K
Effective tax rate
-11.76%
-1.75%
-0.02%
-0.66%
Other operating expenses
-
-
-
-
Net income
-969.00K
-407.00K
-37.60M
-16.72M
Net profit margin
-0.88%
-0.33%
-39.80%
-13.83%
Earnings per share
-
-
-0.15
-0.07
Interest and investment income
-
-
-
-
Interest expense
-7.98M
-7.58M
-6.92M
-6.22M
Net interest expenses
-7.98M
-7.58M
-6.92M
-6.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
5.57M
6.02M
-31.88M
-11.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps